Cited by 103Viral Infections and Immunology ResearchEvolution and Genetic DynamicsVirology and Viral Diseases

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease

Open access

Cherkasova, Elena A., Korotkova, Ekaterina A., Yakovenko, Maria L., Ivanova, Olga E., Eremeeva, Tatyana P., Chumakov, Konstantin M., Agol, Vadim I.·2002·Journal of Virology

DOI 10.1128/jvi.76.13.6791-6799.2002PMC PMC136293

Open this paper in CoChat — free account

Abstract

Successful implementation of the global poliomyelitis eradication program raises the problem of vaccination against poliomyelitis in the posteradication era. One of the options under consideration envisions completely stopping worldwide the use of the Sabin vaccine. This strategy is based on the assumption that the natural circulation of attenuated strains and their derivatives is strictly limited. Here, we report the characterization of a highly evolved derivative of the Sabin vaccine strain isolated in a case of paralytic poliomyelitis from a 7-month-old immunocompetent baby in an apparently adequately immunized population. Analysis of the genome of this isolate showed that it is a double (type 1-type 2-type 1) vaccine-derived recombinant. The number of mutations accumulated in both the type 1-derived and type 2-derived portions of the recombinant genome suggests that both had diverged from their vaccine predecessors ∼2 years before the onset of the illness. This fact, along with other recent observations, points to the possibility of long-term circulation of Sabin vaccine strain derivatives associated with an increase in their neurovirulence. Comparison of genomic sequences of this and other evolved vaccine-derived isolates reveals some general features of natural poliovirus evolution. They include a very high preponderance and nonrandom distribution of synonymous substitutions, conservation of secondary structures of important cis -acting elements of the genome, and an apparently adaptive character of most of the amino acid mutations, with only a few of them occurring in the antigenic determinants. Another interesting feature is a frequent occurrence of tripartite intertypic recombinants with either type 1 or type 3 homotypic genomic ends.

Integrity signals

Registry

Crossref · 10.1128/jvi.76.13.6791-6799.2002

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · Electrophoresis · doi:10.1002/elps.1150181505 · Cited by 11,312
RASMOL: biomolecular graphics for all
Sayle, R. A. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89080-5 · Cited by 2,587
Three-Dimensional Structure of Poliovirus at 2.9 Å Resolution
Hogle, J. M., Chow, M., & Filman, D. J. (1985) · Science · doi:10.1126/science.2994218 · Cited by 1,267
A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes.
Li, W., Wu, C., & Luo, C. C. (1985) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040343 · Cited by 1,053
Origin and Evolution of Viruses
Holland, J. J., & Domingo, E. (1998) · Virus Genes · doi:10.1023/a:1007989407305 · Cited by 524
Fitness of RNA virus decreased by Muller’s ratchet
Chao, L. (1990) · Nature · doi:10.1038/348454a0 · Cited by 488
Complete nucleotide sequences of all three poliovirus serotype genomes
Toyoda, H., Kohara, M., Kataoka, Y., Suganuma, T., Omata, T., Imura, N., & Nomoto, A. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90084-6 · Cited by 415
WORLD HEALTH ASSEMBLY
Turner, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92377-5 · Cited by 388
New model for the secondary structure of the 5′ non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence
Skinner, M. A., Racaniello, V. R., Dunn, G., Cooper, J., Minor, P. D., & Almond, J. W. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90261-1 · Cited by 297

Show all 76 references

Research works printed but not linked: 2

Kimman, T. F., M. P. Koopmans, and H. G. van der Avoort. 1998. Ending polio immunization. Science 279 : 788-789.
King, A. M. Q. 1988. Genetic recombination in positive strand RNA viruses, p. 149-165. In E. Domingo, J. J. Holland, and P. Ahlquist (ed.), RNA Genetics. CRC Press, Inc., Boca Raton, Fla.

Sorted by citations

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Pathogen recognition and development of particulate vaccines: Does size matter?
Xiang, S. D., Scholzen, A., Minigo, G., David, C. T., Apostolopoulos, V., Mottram, P. L., & Plebanski, M. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.016 · Cited by 602
Immunity in response to particulate antigen-delivery systems
Storni, T., Kündig, T. M., Senti, G., & Johansen, P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.008 · Cited by 315
Evidence for Frequent Recombination within SpeciesHuman Enterovirus BBased on Complete Genomic Sequences of All Thirty-Seven Serotypes
Oberste, M. S., Maher, K., & Pallansch, M. A. (2003) · Journal of Virology · doi:10.1128/jvi.78.2.855-867.2004 · Cited by 258
Circulating vaccine-derived polioviruses: current state of knowledge.
Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862004000100006 · Cited by 257
Self-citation
Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines
Benne, N., van Duijn, J., Kuiper, J., Jiskoot, W., & Slütter, B. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.033 · Cited by 247
Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication
Tebbens, R. J. D., Pallansch, M. A., Kew, O. M., Cáceres, V. M., Jafari, H. S., Cochi, S. L., Sutter, R. W., Aylward, R. B., & Thompson, K. M. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00827.x · Cited by 175
Circulation of type 1 vaccine-derived poliovirus in the philippines in 2001
Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13512-13521.2004 · Cited by 146
Polio eradication: the OPV paradox
Dowdle, W. R., De Gourville, E., Kew, O. M., Pallansch, M. A., & Wood, D. J. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.401 · Cited by 144
RNA Recombination Plays a Major Role in Genomic Change during Circulation of Coxsackie B Viruses
Oberste, M. S., Peñaranda, S., & Pallansch, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2948-2955.2004 · Cited by 137
Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence
Combelas, N., Holmblat, B., Joffret, M.-L., Colbère-Garapin, F., & Delpeyroux, F. (2011) · Viruses · doi:10.3390/v3081460 · Cited by 135
Aseptic meningitis: Case definition and guidelines for collection, analysis and presentation of immunization safety data
Tapiainen, T., Prevots, R., Izurieta, H. S., Abramson, J. S., Bilynsky, R., Bonhoeffer, J., Bonnet, M.-C., Galama, J. M. D., Gillard, P. H., Griot, M., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.058 · Cited by 111
Vaccines, Vaccination, and Vaccinology
Plotkin, S. A. (2003) · The Journal of Infectious Diseases · doi:10.1086/374419 · Cited by 109
Characterization of a Highly Evolved Vaccine-Derived Poliovirus Type 3 Isolated from Sewage in Estonia
Blomqvist, S., Savolainen, C., Laine, P., Hirttiö, P., Lamminsalo, E., Penttilä, E., Jöks, S., Roivainen, M., & Hovi, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4876-4883.2004 · Cited by 104
Microarray analysis of evolution of RNA viruses: Evidence of circulation of virulent highly divergent vaccine-derived polioviruses
Cherkasova, E., Laassri, M., Chizhikov, V., Korotkova, E., Dragunsky, E., Agol, V. I., & Chumakov, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633511100 · Cited by 101
Self-citation
Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine‐Derived Polioviruses (cVDPVs)
Tebbens, R. J. D., Pallansch, M. A., Kim, J., Burns, C. C., Kew, O. M., Oberste, M. S., Diop, O. M., Wassilak, S. G. F., Cochi, S. L., & Thompson, K. M. (2013) · Risk Analysis · doi:10.1111/risa.12022 · Cited by 102
A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region
Arita, M., Zhu, S.-L., Yoshida, H., Yoneyama, T., Miyamura, T., & Shimizu, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12650-12657.2005 · Cited by 95
In vivo evolution of viral virulence: switching of deformed wing virus between hosts results in virulence changes and sequence shifts
Gisder, S., Möckel, N., Eisenhardt, D., & Genersch, E. (2018) · Environmental Microbiology · doi:10.1111/1462-2920.14481 · Cited by 92
Vaccination against polio should not be stopped
Chumakov, K., Ehrenfeld, E., Wimmer, E., & Agol, V. I. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1769 · Cited by 82
Self-citation
Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis
Pliaka, V., Kyriakopoulou, Z., & Markoulatos, P. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.28 · Cited by 78
Parallel ClickSeq and Nanopore sequencing elucidates the rapid evolution of defective-interfering RNAs in Flock House virus
Jaworski, E. A., & Routh, A. L. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006365 · Cited by 74
Retrospective Analysis of a Local Cessation of Vaccination against Poliomyelitis: a Possible Scenario for the Future
Korotkova, E. A., Park, R., Cherkasova, E. A., Lipskaya, G. Y., Chumakov, K. M., Feldman, E. V., Kew, O. M., & Agol, V. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12460-12465.2003 · Cited by 73
Self-citation
Molecular Mechanisms of Poliovirus Variation and Evolution
Agol, V. I. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-26397-7_8 · Cited by 73
Self-citation
Vaccine-derived polioviruses
Agol, V. I. (2006) · Biologicals · doi:10.1016/j.biologicals.2006.02.007 · Cited by 68
Self-citation
Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria
Müller, T., Bätza, H.-J., Beckert, A., Bunzenthal, C., Cox, J. H., Freuling, C. M., Fooks, A. R., Frost, J. W., Geue, L., Hoeflechner, A., et al. (2009) · Archives of Virology · doi:10.1007/s00705-009-0408-7 · Cited by 68
Estimating the Extent of Vaccine-Derived Poliovirus Infection
Wringe, A., Fine, P., Sutter, R. W., & Kew, O. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003433 · Cited by 70
Mechanisms of genetic variation in polioviruses
Savolainen‐Kopra, C., & Blomqvist, S. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.663 · Cited by 67
Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child
Adu, F., Iber, J. C., Bukbuk, D. N., Gumede, N., Yang, S.-J., Jorba, J. C., Campagnoli, R. P., Sule, W. F., Yang, C.-F., Burns, C. C., et al. (2007) · Virus Research · doi:10.1016/j.virusres.2007.03.009 · Cited by 63
Long-Term Excretion of Vaccine-Derived Poliovirus by a Healthy Child
Martín, J. E.-S., Odoom, J. K., Tuite, G., Dunn, G., Hopewell, N., Cooper, G., Fitzharris, C., BUTLER, K. M., Hall, W. W., & Minor, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13839-13847.2004 · Cited by 63
Antigenic Evolution of Vaccine-Derived Polioviruses: Changes in Individual Epitopes and Relative Stability of the Overall Immunological Properties
Yakovenko, M. L., Cherkasova, E. A., Rezapkin, G. V., Ivanova, O. E., Ap, I., Eremeeva, T. P., Baykova, O. Y., Chumakov, K. M., & Agol, V. I. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2641-2653.2006 · Cited by 62
Self-citation
Spread of Vaccine-Derived Poliovirus from a Paralytic Case in an Immunodeficient Child: an Insight into the Natural Evolution of Oral Polio Vaccine
Cherkasova, E. A., Yakovenko, M. L., Rezapkin, G. V., Korotkova, E. A., Ivanova, O. E., Eremeeva, T. P., Krasnoproshina, L. I., Romanenkova, N. I., Rozaeva, N. R., Sirota, L., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1062-1070.2005 · Cited by 55
Self-citation
Isolation of Sabin-Like Polioviruses from Wastewater in a Country Using Inactivated Polio Vaccine
Zurbriggen, S., Tobler, K., Abril, C. E., Diedrich, S., Ackermann, M., Pallansch, M. A., & Metzler, A. E. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02764-07 · Cited by 55
Vaccines: New Generation of Inactivated Poliovirus Vaccines for Universal Immunization after Eradication of Poliomyelitis
Chumakov, K., & Ehrenfeld, E. (2008) · Clinical Infectious Diseases · doi:10.1086/593310 · Cited by 54
Self-citation
Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts
Quinlivan, M., Gershon, A. A., Al‐Bassam, M. M., Steinberg, S. P., LaRussa, P. S., Nichols, R. A., & Breuer, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605688104 · Cited by 53
Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children.
Joffret, M.-L., Jégouic, S., Bessaud, M., Balanant, J., Tran, C., Caro, V., Holmblat, B., Razafindratsimandresy, R., Reynes, J.-M., Rakoto-Andrianarivelo, M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis204 · Cited by 44
Genomic Analysis of Vaccine-Derived Poliovirus Strains in Stool Specimens by Combination of Full-Length PCR and Oligonucleotide Microarray Hybridization
Laassri, M., Dragunsky, E. M., Enterline, J. C., Eremeeva, T. P., Ivanova, O. E., Lottenbach, K. R., Belshe, R. B., & Chumakov, K. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2886-2894.2005 · Cited by 43
Self-citation
Changes in Population Dynamics during Long-Term Evolution of Sabin Type 1 Poliovirus in an Immunodeficient Patient
Odoom, J. K., Yunus, Z., Dunn, G., Minor, P. D., & Martín, J. E.-S. (2008) · Journal of Virology · doi:10.1128/jvi.00468-08 · Cited by 42
Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits
Guillon, C., Mayol, K., Terrat, C., Compagnon, C., Primard, C., Charles, M., Delair, T., Munier, S., & Verrier, B. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.08.060 · Cited by 41
Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine
Chen, C.-W., Lee, Y.-P., Wang, Y., & Yu, C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.094 · Cited by 34
Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010
Drexler, J. F., Grard, G., Lukashev, A. N., Kozlovskaya, L. I., Böttcher, S., Uslu, G., Reimerink, J. H. J., Gmyl, A. P., Taty, R. T., Lekana-Douki, S. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323502111 · Cited by 32
Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant
Dedepsidis, E., Pliaka, V., Kyriakopoulou, Z., Brakoulias, C., Levidiotou-Stefanou, S., Pratti, A., Mamuris, Z., & Markoulatos, P. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00381.x · Cited by 32
Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method
Rezapkin, G. V., Martín, J. E.-S., & Chumakov, K. (2005) · Biologicals · doi:10.1016/j.biologicals.2004.11.001 · Cited by 32
Self-citation
Viral mouse models of multiple sclerosis and epilepsy: Marked differences in neuropathogenesis following infection with two naturally occurring variants of Theiler's virus BeAn strain
Bröer, S., Hage, E., Käufer, C., Gerhauser, I., Anjum, S. M. M., Li, L., Baumgärtner, W., Schulz, T. F., & Löscher, W. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.020 · Cited by 30
Retrospective Characterization of a Vaccine-Derived Poliovirus Type 1 Isolate from Sewage in Greece
Dedepsidis, E., Kyriakopoulou, Z., Pliaka, V., Kottaridi, C., Bolanaki, E., Levidiotou-Stefanou, S., Komiotis, D., & Markoulatos, P. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00535-07 · Cited by 27
Strength in numbers: Mechanisms of viral co-infection
Aguilera, E. R., & Pfeiffer, J. K. (2019) · Virus Research · doi:10.1016/j.virusres.2019.03.003 · Cited by 26
Shedding of Vaccine Viruses with Increased Antigenic and Genetic Divergence after Vaccination of Newborns with Monovalent Type 1 Oral Poliovirus Vaccine
van der Sanden, S., Pallansch, M. A., van de Kassteele, J., El-Sayed, N., Sutter, R. W., Koopmans, M., & van der Avoort, H. (2009) · Journal of Virology · doi:10.1128/jvi.02388-08 · Cited by 24
Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV)
Rezapkin, G. V., Dragunsky, E. M., & Chumakov, K. (2005) · Biologicals · doi:10.1016/j.biologicals.2004.11.003 · Cited by 24
Self-citation
Genomic Analysis of Recombinant Sabin Clinical Isolates
Paximadi, E., Karakasiliοtis, I., Mamuris, Z., Stathopoulos, C., Krikelis, V., & Markoulatos, P. (2006) · Virus Genes · doi:10.1007/s11262-005-6877-1 · Cited by 24
A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus
Korotkova, E. A., Gmyl, A. P., Yakovenko, M. L., Ivanova, O. E., Eremeeva, T. P., Kozlovskaya, L. I., Shakaryan, A. K., Lipskaya, G. Y., Parshina, I. L., Loginovskikh, N. V., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00277-16 · Cited by 23
Self-citation
Correlation between recombination junctions and RNA secondary structure elements in poliovirus Sabin strains
Dedepsidis, E., Kyriakopoulou, Z., Pliaka, V., & Markoulatos, P. (2010) · Virus Genes · doi:10.1007/s11262-010-0512-5 · Cited by 22
Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1
Blomqvist, S., Savolainen‐Kopra, C., Paananen, A., Bassioni, L. E., Nasr, E. M. E. M., Firstova, L., Zamiatina, N. A., Kutateladze, T., & Roivainen, M. (2010) · Virus Research · doi:10.1016/j.virusres.2010.05.006 · Cited by 22
Current immunizations for travel
Kirkpatrick, B. D., & Alston, W. K. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200310000-00001 · Cited by 21
Microbiological Quality of Water
(2022) · Wiley eBooks · doi:10.1002/9781119820086.ch3 · Cited by 21
Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania
Combiescu, M., Guillot, S., Persu, A., Băicuş, A., Pițigoi, D., Balanant, J., Oprişan, G., Crainic, R., Delpeyroux, F., & Aubert-Combiescu, A. (2006) · Archives of Virology · doi:10.1007/s00705-006-0884-y · Cited by 18
Picornavirus Genetics: an Overview
Agol, V. I. (2014) · ASM Press eBooks · doi:10.1128/9781555817916.ch22 · Cited by 18
Self-citation
Use of a Multiple Restriction Fragment Length Polymorphism Method for Detecting Vaccine-Derived Polioviruses in Clinical Samples
Romanenkova, N. I., Guillot, S., Rozaeva, N. R., Crainic, R., Бичурина, М. А., & Delpeyroux, F. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00017-06 · Cited by 16
Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine
Dedepsidis, E., Karakasiliοtis, I., Paximadi, E., Kyriakopoulou, Z., Komiotis, D., & Markoulatos, P. (2006) · Virus Genes · doi:10.1007/s11262-005-0055-3 · Cited by 16
Excretion of Wild-Type and Vaccine-Derived Poliovirus in the Feces of Poliovirus Receptor-Transgenic Mice
Boot, H. J., Kasteel, D., Buisman, A., & Kimman, T. G. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6541-6545.2003 · Cited by 16
Recombinant Sabin environmental isolates in Greece and Cyprus
Paximadi, E., Karakasiliοtis, I., Papaventsis, D. C., Papageorgiou, G. T., & Markoulatos, P. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03649.x · Cited by 15
Vaccine-associated paralytic poliomyelitis in the Russian Federation in 1998–2014
Ivanova, O. E., Eremeeva, T. P., Morozova, N. S., Shakaryan, A. K., Korotkova, E. A., Kozlovskaya, L. I., Baykova, O. Y., Krasota, A. Y., & Gmyl, A. P. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.08.017 · Cited by 14
Self-citation
Direct extraction and molecular characterization of enteroviruses genomes from human faecal samples
Bolanaki, E., Kottaridi, C., Dedepsidis, E., Kyriakopoulou, Z., Pliaka, V., Pratti, A., Levidiotou-Stefanou, S., & Markoulatos, P. (2008) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2007.12.001 · Cited by 13
Vaccine-derived poliovirus surveillance in China during 2001–2013: the potential challenge for maintaining polio free status
Wang, H., Luo, H., Li, L., Fan, C., Hao, L., Ma, C., Su, Q., Yang, H., Reilly, K. H., Wang, H., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2849-z · Cited by 12
Growth kinetic analysis of bi-recombinant poliovirus vaccine strains
Pliaka, V., Dedepsidis, E., Kyriakopoulou, Z., Papadi, G., Tsakogiannis, D., Pratti, A., Levidiotou-Stefanou, S., & Markoulatos, P. (2010) · Virus Genes · doi:10.1007/s11262-010-0448-9 · Cited by 9
Use of mutational pattern in 5′-NCR and VP1 regions of polioviruses for molecular diagnosis
Pliaka, V., Dedepsidis, E., Kyriakopoulou, Z., Papadopoulou, I., Levidiotou, S., & Markoulatos, P. (2007) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2007.01.004 · Cited by 8
Polio and Its Epidemiology
Shulman, L. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5719-0_10 · Cited by 7
The role of vaccine derived polioviruses in the global eradication of polio-the Nigeria experience as a case study
Okonko, I. O., Babalola, E. T., Adedeji, A. O., Onoja, A. B., Ogun, A. A., Nkang, A. O., & Adu, F. D. (2008) · Biotechnology and Molecular Biology Reviews · doi:10.5897/bmbr2008.0012 · Cited by 7
Vaccine-associated paralytic poliomyelitis in a child: fast transformation from Sabin-like virus to vaccine-derived poliovirus triggered an epidemiological response in two countries of the European region
Ivanova, O. E., Kozlovskaya, L. I., Eremeeva, T. P., Shakaryan, A. K., Ap, I., Baykova, O. Y., Krasota, A. Y., Shustova, E. Y., Mustafina, A. N., Morozova, N. S., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.09.034 · Cited by 7
Self-citation
Three cases of paralytic poliomyelitis associated with type 3 vaccine poliovirus strains in Bulgaria
Korsun, N., Kojouharova, M., Vladimirova, N., Fiore, L., Litvinenko, I., Buttinelli, G., Fiore, S., Voynova‐Georgieva, V., Mladenova, Z., & Georgieva, D. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21545 · Cited by 7
Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains
Pliaka, V., Kyriakopoulou, Z., Tsakogiannis, D., Ruether, I. G. A., Gartzonika, C., Levidiotou-Stefanou, S., Krikelis, A., & Markoulatos, P. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1033-9 · Cited by 7
Vaccine-associated paralytic poliomyelitis in Russian Federation during the period of changes in vaccination schedule (2006-2013 y.y.)
Ivanova, O. E., Eremeeva, T. P., Morozova, N. S., Shakaryan, A. K., Gmyl, A. P., Yakovenko, M. L., Korotkova, E. A., Chernjavskaja, O. P., Baykova, O. Y., Silenova, O. V., et al. (2016) · Problems of Virology · doi:10.18821/0507-4088-2016-61-1-9-15 · Cited by 7
Self-citation
Construction of a Cloning System for the Mass Production of a Virus-Binding Protein Specific for Poliovirus Type 1
Sano, D., & Omura, T. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.5.2608-2615.2005 · Cited by 6
Direct extraction of Sabin poliovirus genomes from human fecal samples using a guanidine thiocyanate extraction method
Old, M. O., Martinez, C. V., Kwock, D., García, J. J., Martin, G., Chan, C. S., & Maldonado, Y. (2003) · Journal of Virological Methods · doi:10.1016/s0166-0934(03)00133-2 · Cited by 6
Épidémie de poliovirus circulants dérivés de souches vaccinales de type 2 en République démocratique du Congo de 2011 à 2012
Bazira, L., Coulibaly, T., Mayenga, M., Ncharre, C., Yogolelo, R., Mbule, A., Moudzeo, H., Lwamba, P., Mulumba, A., & Cabore, J. W. (2015) · Bulletin de la Société de pathologie exotique · doi:10.1007/s13149-015-0447-4 · Cited by 4
Evolution of Type 2 Vaccine Derived Poliovirus Lineages. Evidence for Codon-Specific Positive Selection at Three Distinct Locations on Capsid Wall
Hovi, T., Savolainen‐Kopra, C., Smura, T., Blomqvist, S., Al‐Hello, H., & Roivainen, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066836 · Cited by 4
Polio and Its Epidemiology
Shulman, L. M. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0851-3_839 · Cited by 4
PCR assays for the identification of rare recombination types from VP1 to 3D genomic region of vaccine derived poliovirus strains
Dimitriou, T. G., Pliaka, V., Kyriakopoulou, Z., Ruether, I. G. A., Tsakogiannis, D., Fountoucidou, P., Gartzonika, C., Levidiotou-Stefanou, S., & Markoulatos, P. (2013) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2013.10.004 · Cited by 3
Retrospective molecular and phenotypic analysis of poliovirus vaccine strains isolated in Greece
Pliaka, V., Filliponi, M. E., Kyriakopoulou, Z., Ruether, I. G. A., Tsakogiannis, D., Gartzonika, C., Levidiotou-Stefanou, S., & Markoulatos, P. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03470.x · Cited by 3
Role of Non-Polioviruses in Acute Flaccid Paralysis (AFP)
Abbasian, F., Saberbaghi, T., & Moosapour, A. (2012) · Journal of Gastroenterology and Hepatology Research · Cited by 3
Determination of antigenic properties of vaccine derived poliovirus strains
Pliaka, V., Achilleos, C., Kyriakopoulou, Z., Tsakogiannis, D., Ruether, I. G. A., Gartzonica, C., Levidiotou-Stefanou, S., & Markoulatos, P. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.028 · Cited by 3
Poliovirus serotype 2 and coxsackievirus A promote the natural recombination of poliovirus
Qian, Y., Pu, X., Yu, Y., Yu, X., Kong, L., Liu, L., Wang, H. X., & Shen, H. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25620 · Cited by 3
APOBEC3A is the predominant global editor of cytosines in human mRNAs and in single-strand RNA viruses
Kockler, Z. W., Bostan, H., Klimczak, L. J., Hsiao, Y.-C., Dennen, M. S., Cook, M. E., Mertz, T. M., Perelygina, L. M., Kazanov, M. D., Li, J., et al. (2026) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkag080 · Cited by 2
Will the three steps for containment of poliovirus be enough to convince policy-makers?
Schoub, B. D. (2004) · Europe PMC (PubMed Central) · Cited by 2
Ignored Outcomes of Polio Eradication
Chakravarthi, I. (2009) · Cited by 1
In pursuit of intriguing puzzles
Agol, V. I. (2019) · Virology · doi:10.1016/j.virol.2019.10.006 · Cited by 1
Self-citation
Microarray analysis: The evolving story of oral polio vaccines
Breuer, J. (2003) · Heredity · doi:10.1038/sj.hdy.6800373 · Cited by 1
Genetics of Vertebrate Viruses
Pringle, C. R. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0217 · Cited by 1
Genomic mutations in oral poliovirus vaccine strains : implications for the eradication of poliovirus
Pavlov, D. N. (2004) · UpSpace Institutional Repository (University of Pretoria)
Arranjos supramoleculares de oligodeoxinucleotídeos e fragmentos de bicamada catiônica: preparação, caracterização e atividade imunoadjuvante
Rozenfeld, J. H. K. (2011) · doi:10.11606/t.46.2011.tde-25042011-135215
Desarrollo de nuevos vehículos para la administración de vacunas genéticas
Csaba, N. (2005) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Quantitative analysis of trade-offs and model input sensitivities in public health
Tebbens, R. J. D. (2005)
Development of a multiplex RT-PCR assay for the identification of recombination types at different genomic regions of vaccine-derived polioviruses
Dimitriou, T. G., Kyriakopoulou, Z., Tsakogiannis, D., Fikatas, A., Gartzonika, C., Levidiotou-Stefanou, S., & Markoulatos, P. (2016) · Virus Genes · doi:10.1007/s11262-016-1333-y
Stochastische Modellierung von Exitstrategien der Poliomyelitis
Krampol, M. (2007)
Μοριακή ανίχνευση νοροϊών - πολιοϊών στο περιβάλλον. Εντοπισμός γενετικών ανασυνδυασμών και σύνδεσή τους με την αντιγραφική λειτουργία των ιϊκών στελεχών
Pliaka, V. (2010) · doi:10.12681/eadd/18309
Untranslated region-5’ and viral protein 1-based genetic stability analysis of bulk polio in Indonesia 2010-2019
Yasmon, A., Normasari, N., Fithriyah, F., & Fadilah, F. (2021) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci005304202106
Polio and Its Epidemiology
Shulman, L. M. (2020) · Springer eBooks · doi:10.1007/978-1-4939-2493-6_839-3
Polio and Its Epidemiology
Shulman, L. M. (2023) · Encyclopedia of sustainability science and technology series · doi:10.1007/978-1-0716-2463-0_839
Surveillance of acute flaccidparalysis and poliomyelitison some territories of Russia and South Vietnam. Part 1. Polioviruses and paralysis
Romanenkova, N. I., Nguyen, T. T. T., Rozaeva, N. R., Kanaeva, O. I., Evseeva, V. A., & Александровна, Б. М. (2023) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-soa-3403
Ανασυνδυασμένα στελέχη πολιοϊών - θέσεις γενετικού ανασυνδυασμού
Paximadi, E. (2009) · doi:10.12681/eadd/17217
VP1 molecular evolution of type 2 immunodeficiency-related vaccine-derived polioviruses (iVDPV2) in a patient with primary immunodeficiency disease (PID)
Nejati, A., Khodakhah, F., Soheili, P., Yousefi, M., Mollaei-Kandelous, Y., Keyvanlou, M., Razaghi, M., Yaghoubzadeh, D., Zahraei, S. M., Mahmoudi, S., et al. (2026) · Virus Genes · doi:10.1007/s11262-026-02214-1
Epidemiological surveillance for poliomyelitis and acute flaccid paralysis in the Russian Federation in 2013–2024
Mikhailova, Y. M., Chirova, A. V., Cherepanova, E. A., Morozova, N. S., Shakaryan, A. K., Kozlovskaya, L. I., & Ivanova, O. E. (2026) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-863
Self-citation

Authors: Cherkasova, E. A., Korotkova, E. A., Yakovenko, M. L., Ivanova, O. E., Eremeeva, T. P., Chumakov, K. M., & Agol, V. I.
Affiliations: Center for Biologics Evaluation and Research (US)
Lomonosov Moscow State University (RU)
Chumakov Institute of Poliomyelitis and Viral Encephalitides (RU)
ORCID: Cherkasova, Elena A.
Ivanova, Olga E.
Eremeeva, Tatyana P.
Agol, Vadim I.
Venue: Journal of Virology
Publisher: American Society for Microbiology
Published: 2002-07
Volume: 76
Issue: 13
Pages: 6791-6799
ISSN: 0022-538X (ISSN-L)
1098-5514
DOI: 10.1128/jvi.76.13.6791-6799.2002
PMC: PMC136293
OpenAlex: W2141343601
Cited by: 103
References: 76
Citations by year: 2026: 3 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 5 · 2015: 1 · 2014: 2 · 2013: 3 · 2012: 6
FWCI: 6.11
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Virology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Defense Advanced Research Projects Agency
Topics: Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
Keywords: vaccine-derived poliovirus, paralytic poliomyelitis, Sabin vaccine strains, poliovirus evolution, intertypic recombination, neurovirulence, synonymous substitutions, cis-regulatory elements, adaptive mutation, antigenic determinants
MeSH terms: Base Sequence, Female, Humans, Infant, Molecular Sequence Data, Mutation, Poliomyelitis, Poliovirus Vaccine, Oral, Genome, Viral, Sequence Analysis, DNA, Poliovirus, Evolution, Molecular, Amino Acid Substitution, 5' Untranslated Regions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks